Trilipix FDA Approval History
FDA Approved: Yes (First approved December 15, 2008)
Brand name: Trilipix
Generic name: fenofibric acid
Dosage form: Delayed-Release Capsules
Company: AbbVie Inc.
Treatment for: Hypertriglyceridemia, High Cholesterol
Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPARĪ±) activator indicated for use along with diet to help lower triglycerides and LDL cholesterol, and to raise HDL cholesterol in patients with lipid problems. Trilipix is the first and only fibrate to be approved for use in combination with a statin.
Development timeline for Trilipix
| Date | Article |
|---|---|
| Dec 15, 2008 | Approval Abbott Receives FDA Approval for Trilipix (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.